Roswell PArk is a clinical research site located in Buffalo, New York, United States 14263.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Roswell PArk has participated in 1 clinical trials.
Therapeutic areas: Newly Diagnosed FLT3 Mutated AML.
Sponsors: Arog Pharmaceuticals, Inc..
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Roswell PArk has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Roswell PArk has 1 clinical trials on record. Their work covers Newly Diagnosed FLT3 Mutated AML.
Roswell PArk has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.